For example, one study reported that while 17% (23 of 137) of patients with salivary gland carcinoma overexpress HER2, only 4% (3 of 70) of patients with ACC overexpress HER2 [72]. This evidence concerns the gene ERBB2 and adrenal cortex carcinoma.